| 15th Apr 2015 7:02 am |
RNS |
Tremelimumab granted Orphan Drug Designation |
| 15th Apr 2015 7:00 am |
RNS |
FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS |
| 1st Apr 2015 11:00 am |
RNS |
Total Voting Rights |
| 30th Mar 2015 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 19th Mar 2015 11:00 am |
RNS |
Notice of AGM |
| 19th Mar 2015 7:00 am |
RNS |
COLLABORATION WITH DAIICHI SANKYO INC |
| 18th Mar 2015 7:04 am |
RNS |
POSITIVE PHASE III RESULTS FOR PT003 IN COPD |
| 16th Mar 2015 7:00 am |
RNS |
BRILINTA PEGASUS-TIMI 54 STUDY |
| 10th Mar 2015 6:24 pm |
RNS |
Filing of Form 20-F with SEC |
| 10th Mar 2015 11:00 am |
RNS |
Annual Financial Report |
| 6th Mar 2015 7:00 am |
RNS |
ASTRAZENECA REFINES ITS FINANCIAL REPORTING |
| 4th Mar 2015 11:54 am |
RNS |
AZ TO PARTICIPATE IN US FDA EMDAC |
| 3rd Mar 2015 7:05 am |
RNS |
Acquisition of Rights to Actavis' Portfolio |
| 2nd Mar 2015 3:00 pm |
RNS |
Total Voting Rights |
| 17th Feb 2015 7:00 am |
RNS |
Directorate Change |
| 16th Feb 2015 7:00 am |
RNS |
PULMICORT RESPULES® US PATENT LITIGATION DECISION |
| 5th Feb 2015 7:02 am |
RNS |
AZ to acquire Actavis' US respiratory portfolio |
| 5th Feb 2015 7:00 am |
RNS |
Final Results |
| 4th Feb 2015 9:00 am |
RNS |
Notice of Results |
| 2nd Feb 2015 2:00 pm |
RNS |
Total Voting Rights |
| 22nd Jan 2015 7:00 am |
RNS |
MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA |
| 14th Jan 2015 7:43 am |
RNS |
BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT |
| 2nd Jan 2015 2:00 pm |
RNS |
Total Voting Rights |
| 19th Dec 2014 5:40 pm |
RNS |
LYNPARZA APPROVED BY THE US FDA |
| 18th Dec 2014 7:00 am |
RNS |
LYNPARZAT APPROVED IN THE EUROPEAN UNION |
| 9th Dec 2014 7:00 am |
RNS |
MOVENTIG approved in the EU for OIC |
| 5th Dec 2014 5:03 pm |
RNS |
Jury verdict favours AZ in Nexium litigation |
| 2nd Dec 2014 7:00 am |
RNS |
New Drug Application for IRESSA accepted by US FDA |
| 1st Dec 2014 2:00 pm |
RNS |
Blocklisting Interim Review |
| 1st Dec 2014 2:00 pm |
RNS |
Total Voting Rights |
| 26th Nov 2014 7:00 am |
RNS |
POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY |
| 24th Nov 2014 4:00 pm |
RNS |
Publication of Final Terms |
| 24th Nov 2014 7:00 am |
RNS |
DUAKLIR GENUAIR APPROVED IN THE EU FOR COPD |
| 19th Nov 2014 5:00 pm |
RNS |
Launch and Pricing of a ?750m Bond |
| 19th Nov 2014 9:41 am |
RNS |
Stabilisation Notice |
| 18th Nov 2014 7:00 am |
RNS |
AZ strategy on track to deliver growth and value |
| 17th Nov 2014 4:00 pm |
RNS |
Publication of Supplementary Prospectus |
| 12th Nov 2014 7:00 am |
RNS |
AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS |
| 10th Nov 2014 2:27 pm |
RNS |
Director/PDMR Shareholding |
| 6th Nov 2014 7:04 am |
RNS |
ASTRAZENECA TO DIVEST MYALEPT TO AEGERION |
